Industry Research Reports
Home > Reports > Medical Devices & Consumables > Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Market Research Report 2024
Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Market Research Report 2024
Industry: Medical Devices & Consumables
Published Date: 2024-08-24
Pages: 79 Pages
Report ld: 3296452
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Extracorporeal membrane oxygenation (ECMO) is an advanced life support technology used to support patients with severe respiratory or circulatory failure. ECMO provides oxygenation and removes carbon dioxide through an extracorporeal circulation system, thereby replacing or assisting the patient's cardiopulmonary function.
The global Extracorporeal Membrane Oxygenation Therapy (ECMO) market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Extracorporeal Membrane Oxygenation Therapy (ECMO) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Extracorporeal Membrane Oxygenation Therapy (ECMO) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Extracorporeal Membrane Oxygenation Therapy (ECMO) include GETINGE, Terumo, NIPRO, Medtronic, LivaNova, XENIOS AG, ALung Technologies, EUROSETS, OriGen Biomedical, MicroPort Scientific, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
REPORT SCOPE
This report aims to provide a comprehensive presentation of the global market for Extracorporeal Membrane Oxygenation Therapy (ECMO), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Extracorporeal Membrane Oxygenation Therapy (ECMO).
The Extracorporeal Membrane Oxygenation Therapy (ECMO) market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Extracorporeal Membrane Oxygenation Therapy (ECMO) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Extracorporeal Membrane Oxygenation Therapy (ECMO) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
GETINGE
Terumo
NIPRO
Medtronic
LivaNova
XENIOS AG
ALung Technologies
EUROSETS
OriGen Biomedical
MicroPort Scientific
Segment by Type
Veinous (VA)
Venous (VV)
Arteriovenous (AV)
Segment by Application
Hospital
Clinic
Other
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Extracorporeal Membrane Oxygenation Therapy (ECMO) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Extracorporeal Membrane Oxygenation Therapy (ECMO) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Extracorporeal Membrane Oxygenation Therapy (ECMO) Market Overview
1.1 Product Definition
1.2 Extracorporeal Membrane Oxygenation Therapy (ECMO) by Type
1.2.1 Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Market Value Comparison by Type (2024-2030)
1.2.2 Veinous (VA)
1.2.3 Venous (VV)
1.2.4 Arteriovenous (AV)
1.3 Extracorporeal Membrane Oxygenation Therapy (ECMO) by Application
1.3.1 Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Market Value by Application (2024-2030)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Market Size Estimates and Forecasts
1.4.1 Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue 2019-2030
1.4.2 Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales 2019-2030
1.4.3 Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Extracorporeal Membrane Oxygenation Therapy (ECMO) Market Competition by Manufacturers
2.1 Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales Market Share by Manufacturers (2019-2024)
2.2 Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Extracorporeal Membrane Oxygenation Therapy (ECMO), Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Extracorporeal Membrane Oxygenation Therapy (ECMO), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Extracorporeal Membrane Oxygenation Therapy (ECMO), Product Type & Application
2.7 Global Key Manufacturers of Extracorporeal Membrane Oxygenation Therapy (ECMO), Date of Enter into This Industry
2.8 Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Market Competitive Situation and Trends
2.8.1 Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Extracorporeal Membrane Oxygenation Therapy (ECMO) Players Market Share by Revenue
2.8.3 Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Market Scenario by Region
3.1 Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales by Region: 2019-2030
3.2.1 Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales by Region: 2019-2024
3.2.2 Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales by Region: 2025-2030
3.3 Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue by Region: 2019-2030
3.3.1 Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue by Region: 2019-2024
3.3.2 Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue by Region: 2025-2030
3.4 North America Extracorporeal Membrane Oxygenation Therapy (ECMO) Market Facts & Figures by Country
3.4.1 North America Extracorporeal Membrane Oxygenation Therapy (ECMO) Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales by Country (2019-2030)
3.4.3 North America Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Extracorporeal Membrane Oxygenation Therapy (ECMO) Market Facts & Figures by Country
3.5.1 Europe Extracorporeal Membrane Oxygenation Therapy (ECMO) Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales by Country (2019-2030)
3.5.3 Europe Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Extracorporeal Membrane Oxygenation Therapy (ECMO) Market Facts & Figures by Region
3.6.1 Asia Pacific Extracorporeal Membrane Oxygenation Therapy (ECMO) Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales by Region (2019-2030)
3.6.3 Asia Pacific Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Extracorporeal Membrane Oxygenation Therapy (ECMO) Market Facts & Figures by Country
3.7.1 Latin America Extracorporeal Membrane Oxygenation Therapy (ECMO) Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales by Country (2019-2030)
3.7.3 Latin America Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Extracorporeal Membrane Oxygenation Therapy (ECMO) Market Facts & Figures by Country
3.8.1 Middle East and Africa Extracorporeal Membrane Oxygenation Therapy (ECMO) Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales by Country (2019-2030)
3.8.3 Middle East and Africa Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales by Type (2019-2030)
4.1.1 Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales by Type (2019-2024)
4.1.2 Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales by Type (2025-2030)
4.1.3 Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales Market Share by Type (2019-2030)
4.2 Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue by Type (2019-2030)
4.2.1 Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue by Type (2019-2024)
4.2.2 Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue by Type (2025-2030)
4.2.3 Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue Market Share by Type (2019-2030)
4.3 Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Price by Type (2019-2030)
5 Segment by Application
5.1 Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales by Application (2019-2030)
5.1.1 Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales by Application (2019-2024)
5.1.2 Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales by Application (2025-2030)
5.1.3 Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales Market Share by Application (2019-2030)
5.2 Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue by Application (2019-2030)
5.2.1 Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue by Application (2019-2024)
5.2.2 Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue by Application (2025-2030)
5.2.3 Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue Market Share by Application (2019-2030)
5.3 Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Price by Application (2019-2030)
6 Key Companies Profiled
6.1 GETINGE
6.1.1 GETINGE Company Information
6.1.2 GETINGE Description and Business Overview
6.1.3 GETINGE Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales, Revenue and Gross Margin (2019-2024)
6.1.4 GETINGE Extracorporeal Membrane Oxygenation Therapy (ECMO) Product Portfolio
6.1.5 GETINGE Recent Developments/Updates
6.2 Terumo
6.2.1 Terumo Company Information
6.2.2 Terumo Description and Business Overview
6.2.3 Terumo Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Terumo Extracorporeal Membrane Oxygenation Therapy (ECMO) Product Portfolio
6.2.5 Terumo Recent Developments/Updates
6.3 NIPRO
6.3.1 NIPRO Company Information
6.3.2 NIPRO Description and Business Overview
6.3.3 NIPRO Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales, Revenue and Gross Margin (2019-2024)
6.3.4 NIPRO Extracorporeal Membrane Oxygenation Therapy (ECMO) Product Portfolio
6.3.5 NIPRO Recent Developments/Updates
6.4 Medtronic
6.4.1 Medtronic Company Information
6.4.2 Medtronic Description and Business Overview
6.4.3 Medtronic Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Medtronic Extracorporeal Membrane Oxygenation Therapy (ECMO) Product Portfolio
6.4.5 Medtronic Recent Developments/Updates
6.5 LivaNova
6.5.1 LivaNova Company Information
6.5.2 LivaNova Description and Business Overview
6.5.3 LivaNova Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales, Revenue and Gross Margin (2019-2024)
6.5.4 LivaNova Extracorporeal Membrane Oxygenation Therapy (ECMO) Product Portfolio
6.5.5 LivaNova Recent Developments/Updates
6.6 XENIOS AG
6.6.1 XENIOS AG Company Information
6.6.2 XENIOS AG Description and Business Overview
6.6.3 XENIOS AG Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales, Revenue and Gross Margin (2019-2024)
6.6.4 XENIOS AG Extracorporeal Membrane Oxygenation Therapy (ECMO) Product Portfolio
6.6.5 XENIOS AG Recent Developments/Updates
6.7 ALung Technologies
6.7.1 ALung Technologies Company Information
6.7.2 ALung Technologies Description and Business Overview
6.7.3 ALung Technologies Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales, Revenue and Gross Margin (2019-2024)
6.7.4 ALung Technologies Extracorporeal Membrane Oxygenation Therapy (ECMO) Product Portfolio
6.7.5 ALung Technologies Recent Developments/Updates
6.8 EUROSETS
6.8.1 EUROSETS Company Information
6.8.2 EUROSETS Description and Business Overview
6.8.3 EUROSETS Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales, Revenue and Gross Margin (2019-2024)
6.8.4 EUROSETS Extracorporeal Membrane Oxygenation Therapy (ECMO) Product Portfolio
6.8.5 EUROSETS Recent Developments/Updates
6.9 OriGen Biomedical
6.9.1 OriGen Biomedical Company Information
6.9.2 OriGen Biomedical Description and Business Overview
6.9.3 OriGen Biomedical Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales, Revenue and Gross Margin (2019-2024)
6.9.4 OriGen Biomedical Extracorporeal Membrane Oxygenation Therapy (ECMO) Product Portfolio
6.9.5 OriGen Biomedical Recent Developments/Updates
6.10 MicroPort Scientific
6.10.1 MicroPort Scientific Company Information
6.10.2 MicroPort Scientific Description and Business Overview
6.10.3 MicroPort Scientific Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales, Revenue and Gross Margin (2019-2024)
6.10.4 MicroPort Scientific Extracorporeal Membrane Oxygenation Therapy (ECMO) Product Portfolio
6.10.5 MicroPort Scientific Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Extracorporeal Membrane Oxygenation Therapy (ECMO) Industry Chain Analysis
7.2 Extracorporeal Membrane Oxygenation Therapy (ECMO) Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Extracorporeal Membrane Oxygenation Therapy (ECMO) Production Mode & Process
7.4 Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales and Marketing
7.4.1 Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales Channels
7.4.2 Extracorporeal Membrane Oxygenation Therapy (ECMO) Distributors
7.5 Extracorporeal Membrane Oxygenation Therapy (ECMO) Customers
8 Extracorporeal Membrane Oxygenation Therapy (ECMO) Market Dynamics
8.1 Extracorporeal Membrane Oxygenation Therapy (ECMO) Industry Trends
8.2 Extracorporeal Membrane Oxygenation Therapy (ECMO) Market Drivers
8.3 Extracorporeal Membrane Oxygenation Therapy (ECMO) Market Challenges
8.4 Extracorporeal Membrane Oxygenation Therapy (ECMO) Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Market Value by Application (2024-2030) & (US$ Million)
Table 3. Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Market Competitive Situation by Manufacturers in 2023
Table 4. Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales (Units) of Key Manufacturers (2019-2024)
Table 5. Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Extracorporeal Membrane Oxygenation Therapy (ECMO) Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Extracorporeal Membrane Oxygenation Therapy (ECMO), Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Extracorporeal Membrane Oxygenation Therapy (ECMO), Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Extracorporeal Membrane Oxygenation Therapy (ECMO), Product Type & Application
Table 12. Global Key Manufacturers of Extracorporeal Membrane Oxygenation Therapy (ECMO), Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Extracorporeal Membrane Oxygenation Therapy (ECMO) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Extracorporeal Membrane Oxygenation Therapy (ECMO) as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales by Region (2019-2024) & (Units)
Table 18. Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales Market Share by Region (2019-2024)
Table 19. Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales by Region (2025-2030) & (Units)
Table 20. Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales Market Share by Region (2025-2030)
Table 21. Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue Market Share by Region (2019-2024)
Table 23. Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue Market Share by Region (2025-2030)
Table 25. North America Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales by Country (2019-2024) & (Units)
Table 27. North America Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales by Country (2025-2030) & (Units)
Table 28. North America Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales by Country (2019-2024) & (Units)
Table 32. Europe Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales by Country (2025-2030) & (Units)
Table 33. Europe Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales by Region (2019-2024) & (Units)
Table 37. Asia Pacific Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales by Region (2025-2030) & (Units)
Table 38. Asia Pacific Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales by Country (2019-2024) & (Units)
Table 42. Latin America Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales by Country (2025-2030) & (Units)
Table 43. Latin America Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue Market Share by Country (2019-2024)
Table 45. Middle East and Africa Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East and Africa Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales by Country (2019-2024) & (Units)
Table 47. Middle East and Africa Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales by Country (2025-2030) & (Units)
Table 48. Middle East and Africa Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East and Africa Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales (Units) by Type (2019-2024)
Table 51. Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales (Units) by Type (2025-2030)
Table 52. Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales Market Share by Type (2019-2024)
Table 53. Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales Market Share by Type (2025-2030)
Table 54. Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue Market Share by Type (2019-2024)
Table 57. Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue Market Share by Type (2025-2030)
Table 58. Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Price (US$/Unit) by Type (2019-2024)
Table 59. Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Price (US$/Unit) by Type (2025-2030)
Table 60. Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales (Units) by Application (2019-2024)
Table 61. Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales (Units) by Application (2025-2030)
Table 62. Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales Market Share by Application (2019-2024)
Table 63. Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales Market Share by Application (2025-2030)
Table 64. Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue Market Share by Application (2019-2024)
Table 67. Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue Market Share by Application (2025-2030)
Table 68. Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Price (US$/Unit) by Application (2019-2024)
Table 69. Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Price (US$/Unit) by Application (2025-2030)
Table 70. GETINGE Company Information
Table 71. GETINGE Description and Business Overview
Table 72. GETINGE Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. GETINGE Extracorporeal Membrane Oxygenation Therapy (ECMO) Product
Table 74. GETINGE Recent Developments/Updates
Table 75. Terumo Company Information
Table 76. Terumo Description and Business Overview
Table 77. Terumo Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Terumo Extracorporeal Membrane Oxygenation Therapy (ECMO) Product
Table 79. Terumo Recent Developments/Updates
Table 80. NIPRO Company Information
Table 81. NIPRO Description and Business Overview
Table 82. NIPRO Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. NIPRO Extracorporeal Membrane Oxygenation Therapy (ECMO) Product
Table 84. NIPRO Recent Developments/Updates
Table 85. Medtronic Company Information
Table 86. Medtronic Description and Business Overview
Table 87. Medtronic Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Medtronic Extracorporeal Membrane Oxygenation Therapy (ECMO) Product
Table 89. Medtronic Recent Developments/Updates
Table 90. LivaNova Company Information
Table 91. LivaNova Description and Business Overview
Table 92. LivaNova Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. LivaNova Extracorporeal Membrane Oxygenation Therapy (ECMO) Product
Table 94. LivaNova Recent Developments/Updates
Table 95. XENIOS AG Company Information
Table 96. XENIOS AG Description and Business Overview
Table 97. XENIOS AG Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. XENIOS AG Extracorporeal Membrane Oxygenation Therapy (ECMO) Product
Table 99. XENIOS AG Recent Developments/Updates
Table 100. ALung Technologies Company Information
Table 101. ALung Technologies Description and Business Overview
Table 102. ALung Technologies Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. ALung Technologies Extracorporeal Membrane Oxygenation Therapy (ECMO) Product
Table 104. ALung Technologies Recent Developments/Updates
Table 105. EUROSETS Company Information
Table 106. EUROSETS Description and Business Overview
Table 107. EUROSETS Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. EUROSETS Extracorporeal Membrane Oxygenation Therapy (ECMO) Product
Table 109. EUROSETS Recent Developments/Updates
Table 110. OriGen Biomedical Company Information
Table 111. OriGen Biomedical Description and Business Overview
Table 112. OriGen Biomedical Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. OriGen Biomedical Extracorporeal Membrane Oxygenation Therapy (ECMO) Product
Table 114. OriGen Biomedical Recent Developments/Updates
Table 115. MicroPort Scientific Company Information
Table 116. MicroPort Scientific Description and Business Overview
Table 117. MicroPort Scientific Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. MicroPort Scientific Extracorporeal Membrane Oxygenation Therapy (ECMO) Product
Table 119. MicroPort Scientific Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Extracorporeal Membrane Oxygenation Therapy (ECMO) Distributors List
Table 123. Extracorporeal Membrane Oxygenation Therapy (ECMO) Customers List
Table 124. Extracorporeal Membrane Oxygenation Therapy (ECMO) Market Trends
Table 125. Extracorporeal Membrane Oxygenation Therapy (ECMO) Market Drivers
Table 126. Extracorporeal Membrane Oxygenation Therapy (ECMO) Market Challenges
Table 127. Extracorporeal Membrane Oxygenation Therapy (ECMO) Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
Table 131. Authors List of This Report
List of Figures
Figure 1. Product Picture of Extracorporeal Membrane Oxygenation Therapy (ECMO)
Figure 2. Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Market Share by Type: 2023 & 2030
Figure 4. Veinous (VA) Product Picture
Figure 5. Venous (VV) Product Picture
Figure 6. Arteriovenous (AV) Product Picture
Figure 7. Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Market Value by Application (2024-2030) & (US$ Million)
Figure 8. Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Market Share by Application: 2023 & 2030
Figure 9. Hospital
Figure 10. Clinic
Figure 11. Other
Figure 12. Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Market Size (2019-2030) & (US$ Million)
Figure 14. Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales (2019-2030) & (Units)
Figure 15. Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Average Price (US$/Unit) & (2019-2030)
Figure 16. Extracorporeal Membrane Oxygenation Therapy (ECMO) Report Years Considered
Figure 17. Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales Share by Manufacturers in 2023
Figure 18. Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue Share by Manufacturers in 2023
Figure 19. Global 5 and 10 Largest Extracorporeal Membrane Oxygenation Therapy (ECMO) Players: Market Share by Revenue in Extracorporeal Membrane Oxygenation Therapy (ECMO) in 2023
Figure 20. Extracorporeal Membrane Oxygenation Therapy (ECMO) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 21. Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 22. North America Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales Market Share by Country (2019-2030)
Figure 23. North America Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue Market Share by Country (2019-2030)
Figure 24. United States Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Canada Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Europe Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales Market Share by Country (2019-2030)
Figure 27. Europe Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue Market Share by Country (2019-2030)
Figure 28. Germany Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. France Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. U.K. Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Italy Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Russia Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Asia Pacific Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales Market Share by Region (2019-2030)
Figure 34. Asia Pacific Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue Market Share by Region (2019-2030)
Figure 35. China Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Japan Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. South Korea Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. India Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Australia Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. China Taiwan Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Southeast Asia Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Latin America Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales Market Share by Country (2019-2030)
Figure 43. Mexico Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Brazil Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Argentina Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Colombia Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Middle East and Africa Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales Market Share by Country (2019-2030)
Figure 48. Middle East and Africa Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue Market Share by Country (2019-2030)
Figure 49. Turkey Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Saudi Arabia Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. UAE Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Global Sales Market Share of Extracorporeal Membrane Oxygenation Therapy (ECMO) by Type (2019-2030)
Figure 53. Global Revenue Market Share of Extracorporeal Membrane Oxygenation Therapy (ECMO) by Type (2019-2030)
Figure 54. Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Price (US$/Unit) by Type (2019-2030)
Figure 55. Global Sales Market Share of Extracorporeal Membrane Oxygenation Therapy (ECMO) by Application (2019-2030)
Figure 56. Global Revenue Market Share of Extracorporeal Membrane Oxygenation Therapy (ECMO) by Application (2019-2030)
Figure 57. Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Price (US$/Unit) by Application (2019-2030)
Figure 58. Extracorporeal Membrane Oxygenation Therapy (ECMO) Value Chain
Figure 59. Extracorporeal Membrane Oxygenation Therapy (ECMO) Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global Extracorporeal Membrane Oxygenation Therapy (ECMO) market?
The top companies in the global Extracorporeal Membrane Oxygenation Therapy (ECMO) market are GETINGE、Terumo、NIPRO.
Related Reports
Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Extracorporeal Membrane Oxygenation Therapy (ECMO) market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-26
Pages: 142
USD 4900.00
(Single User License)
Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Extracorporeal Membrane Oxygenation Therapy (ECMO) market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published Date: 2026-03-26
Pages: 77
USD 4250.00
(Single User License)
Extracorporeal Membrane Oxygenation Therapy (ECMO)- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Extracorporeal Membrane Oxygenation Therapy (ECMO) was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-09
Pages: 97
USD 3950.00
(Single User License)
Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Market Research Report 2026
The global Extracorporeal Membrane Oxygenation Therapy (ECMO) market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-09
Pages: 114
USD 2900.00
(Single User License)
Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Extracorporeal Membrane Oxygenation Therapy (ECMO) market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-08-05
Pages: 132
USD 4900.00
(Single User License)
Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Extracorporeal Membrane Oxygenation Therapy (ECMO) market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-08-01
Pages: 78
USD 4250.00
(Single User License)
Extracorporeal Membrane Oxygenation Therapy (ECMO) - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Extracorporeal Membrane Oxygenation Therapy (ECMO) was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 110
USD 3950.00
(Single User License)
Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Market Research Report 2025
The global market for Extracorporeal Membrane Oxygenation Therapy (ECMO) was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-03-10
Pages: 81
USD 2900.00
(Single User License)
Global and United States Extracorporeal Membrane Oxygenation Therapy (ECMO) Market Report & Forecast 2024-2030
Extracorporeal membrane oxygenation (ECMO) is an advanced life support technology used to support patients with severe respiratory or circulatory failure. ECMO provides oxygenation and removes carbon dioxide through an extracorporeal circulation system, thereby replacing or assisting the patient's cardiopulmonary function.
Published Date: 2024-08-24
Pages: 110
USD 4350.00
(Single User License)
Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Market Insights, Forecast to 2030
Extracorporeal membrane oxygenation (ECMO) is an advanced life support technology used to support patients with severe respiratory or circulatory failure. ECMO provides oxygenation and removes carbon dioxide through an extracorporeal circulation system, thereby replacing or assisting the patient's cardiopulmonary function.
Published Date: 2024-08-24
Pages: 141
USD 4900.00
(Single User License)
Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Extracorporeal Membrane Oxygenation Therapy (ECMO) market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-26
Pages: 142
USD 4900.00 (Single User License)Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Extracorporeal Membrane Oxygenation Therapy (ECMO) market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published: 2026-03-26
Pages: 77
USD 4250.00 (Single User License)Extracorporeal Membrane Oxygenation Therapy (ECMO)- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Extracorporeal Membrane Oxygenation Therapy (ECMO) was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-01-09
Pages: 97
USD 3950.00 (Single User License)Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Market Research Report 2026
The global Extracorporeal Membrane Oxygenation Therapy (ECMO) market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-01-09
Pages: 114
USD 2900.00 (Single User License)Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Extracorporeal Membrane Oxygenation Therapy (ECMO) market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-08-05
Pages: 132
USD 4900.00 (Single User License)Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Extracorporeal Membrane Oxygenation Therapy (ECMO) market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-08-01
Pages: 78
USD 4250.00 (Single User License)Extracorporeal Membrane Oxygenation Therapy (ECMO) - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Extracorporeal Membrane Oxygenation Therapy (ECMO) was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 110
USD 3950.00 (Single User License)Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Market Research Report 2025
The global market for Extracorporeal Membrane Oxygenation Therapy (ECMO) was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-03-10
Pages: 81
USD 2900.00 (Single User License)Global and United States Extracorporeal Membrane Oxygenation Therapy (ECMO) Market Report & Forecast 2024-2030
Extracorporeal membrane oxygenation (ECMO) is an advanced life support technology used to support patients with severe respiratory or circulatory failure. ECMO provides oxygenation and removes carbon dioxide through an extracorporeal circulation system, thereby replacing or assisting the patient's cardiopulmonary function.
Published: 2024-08-24
Pages: 110
USD 4350.00 (Single User License)Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Market Insights, Forecast to 2030
Extracorporeal membrane oxygenation (ECMO) is an advanced life support technology used to support patients with severe respiratory or circulatory failure. ECMO provides oxygenation and removes carbon dioxide through an extracorporeal circulation system, thereby replacing or assisting the patient's cardiopulmonary function.
Published: 2024-08-24
Pages: 141
USD 4900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 2900.00
USD 4350.00
USD 5800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
REPORT SCOPE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now